Intracranial Vascular Procedures with Hemorrhage DRG Reimbursement

Acute endovascular intervention trials: studies focusing on timing, procedural techniques, and peri-procedural management for patients admitted with intracranial hemorrhage who undergo intracranial vascular procedures (for example, endovascular coiling, embolization, or clot evacuation). These trials enroll patients in the hyperacute to acute inpatient period and address questions such as optimal door-to-procedure intervals, blood pressure and anticoagulation management surrounding the procedure, and complication mitigation strategies. Results are directly relevant to surgeons, interventionalists, and hospital administrators because they affect in-hospital mortality, complication rates, length of stay, and resource utilization tied to this DRG.
Comparative effectiveness and safety studies of procedural strategies and adjunctive therapies: observational cohorts or randomized designs comparing different surgical or endovascular approaches, use of adjunctive devices or hemostatic agents, or variations in intensive care protocols among patients with intracranial hemorrhage who require vascular procedures. These studies typically stratify by hemorrhage location, size, and comorbidity burden (including CC-level clinical complexity) to identify which strategies produce better functional outcomes and fewer readmissions. Payors and providers value this evidence to guide care pathways that optimize outcomes while potentially reducing reoperation, complications, and downstream costs associated with the DRG.
Post-discharge outcomes and rehabilitation research: longitudinal studies examining neurological recovery, functional status, and healthcare utilization after hospital discharge for patients who underwent intracranial vascular procedures for hemorrhage, including investigation of predictors of readmission, long-term disability, and needs for downstream services. These studies may test transitional care models, timing and intensity of rehabilitation, and monitoring strategies to reduce preventable rehospitalizations and improve quality-of-life metrics. Findings inform discharge planning, case management, and coverage decisions by payers concerned with 30- and 90-day outcomes and total episode-of-care costs for this high-acuity DRG.

Acute endovascular intervention trials: studies focusing on timing, procedural techniques, and peri-procedural management for patients admitted with intracranial hemorrhage who undergo intracranial vascular procedures (for example, endovascular coiling, embolization, or clot evacuation). These trials enroll patients in the hyperacute to acute inpatient period and address questions such as optimal door-to-procedure intervals, blood pressure and anticoagulation management surrounding the procedure, and complication mitigation strategies. Results are directly relevant to surgeons, interventionalists, and hospital administrators because they affect in-hospital mortality, complication rates, length of stay, and resource utilization tied to this DRG.
Comparative effectiveness and safety studies of procedural strategies and adjunctive therapies: observational cohorts or randomized designs comparing different surgical or endovascular approaches, use of adjunctive devices or hemostatic agents, or variations in intensive care protocols among patients with intracranial hemorrhage who require vascular procedures. These studies typically stratify by hemorrhage location, size, and comorbidity burden (including CC-level clinical complexity) to identify which strategies produce better functional outcomes and fewer readmissions. Payors and providers value this evidence to guide care pathways that optimize outcomes while potentially reducing reoperation, complications, and downstream costs associated with the DRG.
Post-discharge outcomes and rehabilitation research: longitudinal studies examining neurological recovery, functional status, and healthcare utilization after hospital discharge for patients who underwent intracranial vascular procedures for hemorrhage, including investigation of predictors of readmission, long-term disability, and needs for downstream services. These studies may test transitional care models, timing and intensity of rehabilitation, and monitoring strategies to reduce preventable rehospitalizations and improve quality-of-life metrics. Findings inform discharge planning, case management, and coverage decisions by payers concerned with 30- and 90-day outcomes and total episode-of-care costs for this high-acuity DRG.

OpenPayer

Summary & Overview

Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with CC: Inpatient Reimbursement Overview

DRG 021 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes